ALT is a commonly reported liver enzyme, but it is a signal of cell stress rather than a diagnosis. The meaning comes from its size, pattern, timing, and the rest of your liver panel.
Chaidh an stiùireadh seo a sgrìobhadh fo stiùireadh An Dr. Tòmas Klein, MD ann an co-obrachadh leis an Bòrd Comhairleachaidh Meidigeach Kantesti AI, a’ gabhail a-steach tabhartasan bhon Ollamh Dr. Hans Weber agus lèirmheas meidigeach leis an Dr. Sarah Mitchell, MD, PhD.
Tòmas Klein, MD
Prìomh Oifigear Meidigeach, Kantesti AI
Tha an Dr. Thomas Klein na hematologist clionaigeach le teisteanas bùird agus na internist le còrr is 15 bliadhna de eòlas ann an leigheas-lann agus mion-anailis clionaigeach le taic bho AI. Mar Àrd Oifigear Meidigeach aig Kantesti AI, tha e a’ toirt seachad stiùireadh clionaigeach air cruinneas meidigeach an lìonra neural seilbheach. Tha an Dr. Klein air fhoillseachadh mu mhìneachadh biomarcair agus breithneachadh obair-lann.
Sarah Mitchell, MD, PhD
Prìomh Chomhairliche Meidigeach - Paiteòlas Clionaigeach & Leigheas In-ghabhalach
Tha an Dr. Sarah Mitchell na pathologist clionaigeach le teisteanas bùird le còrr is 18 bliadhna de eòlas ann an leigheas-lann agus mion-sgrùdadh breithneachaidh. Tha teisteanasan sònraichte aice ann an ceimigeachd clionaigeach agus tha i air foillseachadh gu farsaing air pannalan biomarkers agus mion-sgrùdadh obair-lann ann an cleachdadh clionaigeach.
An t-Ollamh Dr. Hans Weber, PhD
Àrd-ollamh Leigheas-lann & Bith-cheimigeachd Clionaigeach
Tha am Prof. Dr. Hans Weber a’ toirt 30+ bliadhna de eòlas ann an bith-cheimigeachd clionaigeach, leigheas-lann, agus rannsachadh biomarkers. B’ e seann Cheann-suidhe Comann Ceimigeachd Clionaigeach na Gearmailt a bh’ ann, agus tha e gu sònraichte a’ dèiligeadh ri mion-sgrùdadh phannalan breithneachaidh, àbhaisteachadh biomarkers, agus leigheas-lann le taic AI.
- ALT meaning: ALT stands for alanine aminotransferase, an enzyme measured in IU/L that is concentrated in liver cells.
- Raon àbhaisteach: Many adult laboratories use an ALT upper limit of 35 IU/L for women and 45 IU/L for men, although the report's own range is decisive.
- Àrdachadh tlàth: ALT below 2 times the laboratory upper limit is common and often merits a planned repeat, not panic.
- tha pàtran cudromach: ALT with high AST, ALP, GGT, bilirubin, or INR means something different than isolated ALT elevation.
- Buaidh eacarsaich: Heavy resistance training can increase ALT and AST for 7 days or longer, particularly when creatine kinase is also high.
- Ath-sgrùdadh cungaidh-leigheis: Acetaminophen, statins, antibiotics, antiseizure drugs, supplements, and herbal products can affect ALT.
- Comharraidhean èiginneach: Jaundice, confusion, severe right-upper abdominal pain, repeated vomiting, or very dark urine need same-day clinical assessment.
- Trend value: A falling ALT after removing a trigger is usually more reassuring than one isolated borderline result.
What ALT means on a blood test
ALT stands for alanine aminotransferase, an enzyme that helps cells transfer amino groups during energy metabolism. It is measured because ALT enters the circulation when liver cells are stressed or injured; it does not, by itself, prove permanent liver damage.
ALT is found mainly inside hepatocytes, the working cells of the liver, although small amounts occur in skeletal muscle and other tissues. A raised result means more enzyme reached the sample than expected; it cannot identify fatty liver, hepatitis, medication injury, or exercise without accompanying evidence.
In my clinical practice, the most useful first question is not “how high is it?” but “high compared with what baseline and what other markers?” An ALT of 58 IU/L after a new gym routine is a different problem from ALT 58 IU/L with bilirubin 65 µmol/L and yellow eyes.
Tha Kantesti na Anailisiche deuchainn fala AI that reads ALT alongside AST, ALP, GGT, bilirubin, albumin, platelet count, medicines, and prior results rather than treating one flagged value as a diagnosis. For a broader map of related measurements, see our biomarker guide.
Why the older name SGPT may appear
Some reports still call ALT “serum glutamic-pyruvic transaminase” or SGPT. ALT and SGPT refer to the same enzyme test, although modern laboratory reporting usually uses ALT.
Why clinicians measure alanine aminotransferase
Clinicians order an alanine aminotransferase test to detect hepatocellular stress, monitor known liver disease, and check for medication-related injury. ALT is often included in a liver panel or comprehensive metabolic panel, even when a person has no symptoms.
ALT is commonly checked during diabetes or lipid reviews because metabolic dysfunction-associated steatotic liver disease, previously called fatty liver disease, can be silent for years. The 2023 AASLD guidance advises assessing people with metabolic risk factors and unexplained liver-enzyme elevation for steatotic liver disease and fibrosis risk (Rinella et al., 2023).
A normal ALT does not exclude significant fibrosis, and a high ALT does not measure fibrosis stage. I have seen patients with ALT 24 IU/L and meaningful scarring on specialist assessment, particularly with type 2 diabetes; fibrosis scores and imaging answer a different question.
ALT monitoring is also practical after a medication change, but it should be scheduled thoughtfully. Our guide to annual blood work explains why testing frequency should follow risk, symptoms, and treatment rather than habit alone.
ALT normal ranges and why lab cutoffs vary
Adult ALT reference ranges commonly run from about 7 to 35 IU/L for women and 10 to 45 IU/L for men, but ranges vary by assay, population, and laboratory. Always use the upper limit printed beside your own result rather than an internet cutoff.
The upper limit is statistical, usually derived from a reference population, not a guarantee that every value below it reflects an entirely healthy liver. Some European laboratories use sex-specific upper limits near 25 IU/L for women and 35 IU/L for men, which can identify metabolic risk earlier but also create more borderline flags.
A value under twice the upper limit of normal is often called mild elevation. For a laboratory with an upper limit of 40 IU/L, ALT 55 to 80 IU/L deserves context and usually a repeat plan, whereas ALT 400 IU/L is 10 times the upper limit and changes the urgency.
Dr. Thomas Klein advises patients to save the laboratory name, units, range, draw date, alcohol intake, and exercise in the preceding week. This makes result differences between visits far more interpretable.
How ALT and AST work together
ALT and AST should be interpreted together because ALT is relatively liver-focused while AST is also abundant in skeletal and cardiac muscle. An AST-to-ALT ratio can suggest patterns, but it cannot diagnose alcohol-related disease or cirrhosis alone.
When ALT exceeds AST, clinicians often consider metabolic steatosis, viral hepatitis, or medication effects, though there are plenty of exceptions. An AST:ALT ratio above 2 can occur in alcohol-associated liver injury, but advanced fibrosis, muscle injury, and timing after an acute insult can also shift the ratio.
A 52-year-old marathon runner with AST 89 IU/L, ALT 61 IU/L, and creatine kinase 1,450 IU/L after a race needs a different conversation from someone with the same enzymes and creatine kinase 90 IU/L. The reason we worry about AST plus high CK is muscle release; ALT alone is less muscle-specific but can rise too.
For the muscle side of this distinction, read our explanation of high AST symptoms. If physical activity is a plausible trigger, avoid unusually strenuous training for 7 days before the repeat unless your clinician advises otherwise.
Why ALP, GGT and bilirubin change ALT meaning
ALT indicates a hepatocellular pattern, whereas alkaline phosphatase, GGT, and bilirubin help identify cholestasis or impaired bile flow. ALT plus high ALP and GGT should prompt consideration of bile-duct disease, medication effects, or hepatic inflammation rather than assuming simple fatty liver.
A clinician may calculate an R ratio: ALT divided by its upper limit, then divided by ALP divided by its upper limit. An R ratio of 5 or greater supports hepatocellular injury, 2 or less supports cholestatic injury, and 2 to 5 suggests a mixed pattern; this is a triage tool, not a final diagnosis.
GGT is useful when ALP is elevated because GGT elevation supports a hepatobiliary source, while ALP can also rise from bone turnover. An isolated ALP rise with normal GGT can therefore lead toward bone and vitamin D questions rather than liver imaging.
Dark urine, pale stools, itch, fever, or jaundice with elevated bilirubin are not “wait for the next annual test” symptoms. Our stiùireadh pàtran cholestasis explains the combinations that should be assessed promptly.
Common causes of elevated ALT
Elevated ALT most often reflects metabolic steatotic liver disease, alcohol exposure, viral hepatitis, medication effects, or a temporary exercise-related rise. The probability of each cause changes with body weight, glucose, triglycerides, alcohol pattern, travel, medicines, and the size of the elevation.
Metabolic steatotic liver disease is especially likely when ALT elevation accompanies central weight gain, triglycerides above 150 mg/dL, low HDL cholesterol, raised fasting glucose, or type 2 diabetes. It can occur in people with smaller bodies too, particularly with visceral fat, genetics, sleep apnea, or certain medicines.
Viral hepatitis testing depends on exposure and risk, not ALT alone. Hepatitis B surface antigen and hepatitis C antibody with confirmatory RNA testing are standard parts of a focused evaluation when the history, geography, or enzyme pattern supports it; our hepatitis C guide covers the usual pathway.
Less common but important causes include hemochromatosis, autoimmune hepatitis, Wilson disease in younger people, celiac disease, and alpha-1 antitrypsin deficiency. Dr. Thomas Klein has seen the harm of assuming every elevated ALT is alcohol-related; a structured work-up is kinder and more accurate.
Medicines and supplements that can raise ALT
Medicines and supplements can raise ALT through direct liver injury, altered bile flow, metabolic effects, or an unrelated coincidence. Do not stop a prescribed medicine abruptly because of one result; contact the prescriber who can weigh the drug benefit against the pattern and trend.
Acetaminophen, also called paracetamol, can cause marked ALT elevation in overdose and sometimes milder changes at high therapeutic exposure. For most adults, the usual maximum is 4,000 mg daily, but many clinicians recommend a lower ceiling for people who drink alcohol regularly, have liver disease, are older, or use combination cold remedies.
Statins can produce small ALT increases, yet serious statin-related liver injury is rare; stopping a cardiovascular medicine without advice can be riskier than the enzyme flag. The ACG guideline recommends confirming abnormal liver chemistries and taking a careful prescription, over-the-counter, and supplement history before extensive testing (Kwo et al., 2017).
Green tea extract, anabolic products, high-dose vitamin A, multi-ingredient “detox” powders, and unregulated bodybuilding supplements deserve specific questions because labels can be incomplete. Review our practical supplement safety guide before adding a new product.
Can exercise temporarily increase ALT?
Yes, strenuous exercise can temporarily increase ALT, particularly after unfamiliar resistance training, endurance events, or muscle injury. AST and creatine kinase usually rise more prominently, and values may take 3 to 10 days to settle depending on exercise intensity and muscle mass.
The common misconception is that a raised ALT always means liver damage. In practice, a hard session involving eccentric lifting—slow lowering movements—can disrupt muscle membranes enough to alter AST, ALT, LDH, and CK without an intrinsic liver disorder.
For a clean recheck, I usually ask stable, well patients to avoid vigorous training for 5 to 7 days, avoid alcohol for several days, keep hydration normal, and use the same laboratory when possible. This is not appropriate if there are red-flag symptoms or an ALT several times above range; those situations need clinical advice first.
Tha Kantesti na Inneal mion-sgrùdaidh deuchainn fala le cumhachd AI used across 127+ countries that can compare ALT, AST, CK, and prior draws to flag an exercise-compatible pattern without declaring it harmless. Athletes can also review marathon blood test timing.
Symptoms that make an ALT result more urgent
Most mild ALT elevations cause no symptoms, but jaundice, very dark urine, pale stool, severe abdominal pain, confusion, easy bruising, or persistent vomiting require prompt medical assessment. Symptoms matter because they can indicate impaired bilirubin handling, bile obstruction, acute hepatitis, or reduced liver synthetic function.
Seek same-day care for yellow eyes or skin, confusion, new sleepiness, rapidly worsening pain under the right ribs, or inability to keep fluids down. These symptoms carry more weight when ALT is above 5 times the upper limit, bilirubin is elevated, or INR is prolonged.
Pregnancy changes the threshold for concern: itching of palms or soles, right-upper abdominal discomfort, headache, visual disturbance, or high blood pressure needs urgent obstetric assessment even when ALT is only modestly elevated. Pregnancy-specific conditions require a different pathway from routine outpatient liver testing.
Urine changes can add clues but are not diagnostic by themselves. Our article on dark urine causes helps distinguish dehydration and medicines from bilirubin-related warning signs.
What usually happens after an abnormal ALT result
After an abnormal ALT result, clinicians usually confirm the result, review exposures, and repeat or expand the panel based on the elevation size and symptoms. A single mild result often leads to a repeat in weeks to a few months, while marked elevation or jaundice warrants faster assessment.
A sensible first review includes alcohol pattern, recent illness, body weight changes, travel, family history, prescription and non-prescription drugs, supplements, and exercise during the prior 7 days. Common follow-up tests include AST, ALP, GGT, bilirubin, albumin, full blood count, INR, hepatitis screening, ferritin with transferrin saturation, and glucose or HbA1c.
Ultrasound is often useful for steatosis, gallstones, bile-duct dilation, or structural change, but it does not reliably stage early fibrosis. FIB-4 uses age, AST, ALT, and platelet count to estimate fibrosis risk; it becomes less reliable below age 35 and should not be used during acute illness.
Kantesti AI ’s e seirbheis eadar-mhìneachaidh deuchainn-lann AI that organizes these related markers and longitudinal results for discussion with a clinician. Our liver panel explainer shows what each follow-up component contributes.
Why ALT trends are more useful than one number
An ALT trend is often more informative than a single result because it shows whether the signal is resolving, persistent, or accelerating. A change from 72 to 34 IU/L after 6 weeks carries a different clinical message than 34 to 72 IU/L, even though both numbers may be near a laboratory cutoff.
Biological variation, hydration, assay variation, and timing can move ALT modestly between draws. Repeating at the same laboratory, at a similar time of day, after comparable activity and alcohol exposure, reduces noise and makes a real change easier to identify.
Persistent elevation for more than 6 months merits a more deliberate assessment, particularly with diabetes, obesity, family history of liver disease, platelet decline, or rising bilirubin. Conversely, a stable mild ALT in a thoroughly assessed patient may be monitored rather than chased with repeated broad testing.
Kantesti AI interprets ALT trends with the accompanying AST, platelet count, bilirubin, and metabolic markers rather than treating a 3 IU/L shift as disease progression. See our iùl deuchainn fad-ùine for the details worth recording after each draw.
ALT misconceptions that can lead to poor decisions
ALT is not a “liver function test” in the strict sense because it measures enzyme leakage, not the liver's ability to make albumin, clotting factors, or bile. Albumin, INR, bilirubin, platelet count, symptoms, and imaging may tell a more consequential story than ALT alone.
Normal ALT does not give permission to ignore heavy alcohol intake, diabetes, or a strong family history of liver disease. Likewise, elevated ALT does not prove that alcohol was the cause; this assumption can damage trust and delay diagnosis of viral, autoimmune, genetic, or medication-related conditions.
“Liver detoxes” are another common trap. The liver already handles metabolism and clearance, while aggressive fasting, unregulated herbs, and rapid weight loss can sometimes worsen symptoms or laboratory markers; evidence for commercial detox regimens is honestly poor.
If diet is part of the discussion, focus on sustainable weight change, adequate protein, fiber, and reduced ultra-processed food rather than miracle products. Our evidence-based liver food guide is a safer starting point.
ALT interpretation in children, pregnancy and older age
ALT interpretation needs age-specific context in children, pregnancy, and older adults because reference limits and likely causes differ. Pediatric ALT cutoffs are often lower than adult laboratory ranges, and pregnancy-related liver symptoms require faster specialist-led assessment.
In children, obesity-related steatotic liver disease is increasingly recognized, but viral illnesses, muscle disorders, celiac disease, and inherited metabolic conditions must remain in the differential. A pediatric clinician should interpret persistent ALT elevation rather than applying adult “under 40 IU/L is fine” thinking.
During pregnancy, ALT should generally remain within the non-pregnant reference interval; a rise with hypertension, low platelets, itching, or nausea needs prompt assessment for pregnancy-specific disorders. Albumin commonly falls due to plasma-volume expansion, so albumin and ALT should not be interpreted with the same logic.
In older adults, polypharmacy and frailty increase the value of a full medicine review. Our senior medication lab guide outlines questions to bring to the appointment.
Using AI interpretation safely for ALT results
AI can help organize an ALT result, but it cannot examine you, verify symptoms, or replace medical assessment for a potentially serious liver pattern. The safest use is preparation: identify the pattern, preserve the original report, and bring focused questions to a qualified clinician.
As of September 5, 2026, Kantesti is an àrd-ùrlar mìneachaidh deuchainn fala AI that reviews uploaded laboratory reports in about 60 seconds and places ALT in the context of related values, trend history, and reported medications. It is designed to improve the quality of questions, not to issue a diagnosis or prescribe treatment.
For accuracy, check that the report image is readable, the units are captured correctly, and a result from a prior year is not mistaken for today's value. Kantesti's clinical approach is shaped by physician oversight; readers can review our inbhean dearbhaidh meidigeach agus Bòrd Comhairleachaidh Meidigeach when deciding how to use AI-supported interpretation.
Bring three things to a review: the full panel, a list of every medicine and supplement with doses, and a timeline of alcohol, illness, travel, and intense exercise. That modest preparation often prevents unnecessary alarm and prevents a meaningful pattern from being missed.
A practical checklist before your next ALT test
Before a planned ALT retest, keep your routine steady and document factors that can shift enzymes. Avoid heavy training for 5 to 7 days where clinically safe, avoid alcohol for several days, and do not change prescribed medicines unless the prescriber tells you to.
Record any acetaminophen or paracetamol use, antibiotics, new supplements, recent fever, gastroenteritis, vaccines, fasting, and rapid weight change. Fasting is not usually required for ALT alone, though it may be requested if glucose, triglycerides, or other tests are being measured at the same visit.
Ask the clinician whether repeat ALT should include AST, ALP, GGT, bilirubin, albumin, platelets, and CK. The answer often depends on the first pattern; an isolated ALT of 48 IU/L after weightlifting does not need the same work-up as ALT 248 IU/L with bilirubin 48 µmol/L.
If you need help assembling questions from your report, our liosta-sgrùdaidh cruinneas aithisg AI is useful before the visit. For organizational information about our work, see Mu dheidhinn Kantesti.
Ceistean Bitheanta
Dè tha ALT a' ciallachadh air toraidhean obair-lann?
Tha ALT a’ ciallachadh alanine aminotransferase, enzyme a lorgar gu ìre mhòr ann an ceallan grùthan agus air a thomhas ann an aonaidean eadar-nàiseanta gach liotair (IU/L). Bidh mòran de naobhailean-obrach a’ cleachdadh crìochan àrda timcheall air 35 IU/L airson boireannaich inbheach agus 45 IU/L airson fir inbheach, ged a tha an raon iomraidh a tha clò-bhuailte air an aithisg fa leth mar an comparator ceart. Tha ALT àrdaichte a’ comharrachadh cuideam no leòn cealla ach chan urrainn dha an adhbhar a chomharrachadh leis fhèin. Tha AST, ALP, GGT, bilirubin, cungaidhean-leigheis, deoch làidir, eacarsaich, agus comharran a’ dearbhadh dè tha an toradh a’ ciallachadh.
A bheil ALT 50 IU/L àrd?
Tha ALT de 50 IU/L air a thogail gu ìre bheag ann an obairlannan le crìoch àrd de 35 no 40 IU/L, ach tha e faisg air àbhaisteach ann an cuid de dh’obairlannan le crìoch àrd de 55 IU/L. Mar as trice tha luach timcheall air 50 IU/L nas èiginn nuair a tha bilirubin, ALP, INR, agus comharraidhean àbhaisteach, ged a tha e fhathast airidh air co-theacsa agus gu tric ath-aithris. Is e togail cuideam o chionn ghoirid, deoch-làidir, steatosis metabolach, cungaidhean-leigheis, agus stuthan cur-ris na mhìneachaidhean cumanta. Tha togail leantainneach nas fhaide na 6 mìosan a’ gealltainn ath-sgrùdadh clionaigeach structarail.
An urrainn do eacarsaich ìrean ALT a thogail?
Faodaidh eacarsaich chruaidh na h-ìrean ALT, AST, LDH, agus creatine kinase a thogail leis gu bheil fèithean cnàimhneach a’ leigeil a-mach enzymes às dèidh oidhirp dian no neo-àbhaisteach. Faodaidh an àrdachadh mairsinn airson 3 gu 10 latha, le AST agus creatine kinase gu tric ag èirigh nas motha na ALT. Le bhith a’ seachnadh gnìomhachd chruaidh neo-àbhaisteach airson 5 gu 7 latha ron ath-aithris a chaidh a phlanadh faodaidh sin soilleireachadh an robh eacarsaich an sàs. Tha àrdachadh mòr ann an ALT, buidheachas, pian làidir, no fual dorcha fhathast ag iarraidh comhairle mheidigeach sgiobalta seach a bhith a’ gabhail ris gu bheil eacarsaich an urra ris.
Dè a tha nas cudromaiche, ALT no AST?
Chan eil ALT no AST nas cudromaiche gu h-uile-fhillte leis gu bheil an càraid a’ toirt seachad barrachd fiosrachaidh na toradh sam bith leis fhèin. Tha ALT nas fòcasach air an ae, fhad ‘s a tha AST cuideachd an làthair ann am fèithean cnàimhneach agus faodaidh e èirigh gu mòr às deidh eacarsaich no leòn fèithe. Faodaidh ìre AST gu ALT os cionn 2 tachairt le leòn ae co-cheangailte ri deoch làidir, ach chan eil e dearbhach agus faodaidh e nochdadh cuideachd le fibrosis adhartach no fuasgladh fèithe. Tha luchd-clionaigeach a’ mìneachadh an dà luach leis an GGT, ALP, bilirubin, creatine kinase, àireamh truinnseir, agus an eachdraidh clionaigeach.
When should a high ALT result be treated as urgent?
A high ALT result needs urgent assessment when it is more than 5 times the laboratory upper limit, rises rapidly, or occurs with jaundice, confusion, severe right-upper abdominal pain, persistent vomiting, easy bruising, or very dark urine. Bilirubin elevation, a prolonged INR, low glucose, or low platelets can increase concern because they may indicate more than isolated enzyme release. Pregnancy-related itch, headache, visual symptoms, or high blood pressure with ALT elevation also needs urgent obstetric assessment. An isolated mild result below 2 times the upper limit is usually assessed less urgently but should not be ignored.
Can fatty liver cause high ALT?
Metabolic dysfunction-associated steatotic liver disease is a common cause of mildly elevated ALT, especially with triglycerides above 150 mg/dL, raised glucose, type 2 diabetes, central weight gain, or low HDL cholesterol. ALT can be normal despite liver fat or fibrosis, so a normal result does not rule out clinically relevant disease. The 2023 AASLD guidance supports fibrosis risk assessment in people with metabolic risk factors and unexplained enzyme elevation. Sustainable weight management, diabetes control, alcohol reduction, and clinician-directed monitoring are more evidence-based than detox products.
Faigh Mion-sgrùdadh Deuchainn Fala le Cumhachd AI an-diugh
Thig còmhla ri còrr is 2 mhillean neach air feadh an t-saoghail a tha a’ earbsa Kantesti airson mion-sgrùdadh sa bhad, ceart air deuchainnean obair-lann. Luchdaich suas na toraidhean deuchainn fala agad agus faigh mìneachadh coileanta air biomarcair 15,000+ ann an diogan.
📚 Foillseachaidhean Rannsachaidh le Iomraidhean
Klein, T., Mitchell, S., & Weber, H. (2026). Stuth fala B àicheil, stiùireadh deuchainn fala LDH & cunntas reticulocyte. Rannsachadh Leigheis AI Kantesti.
Klein, T., Mitchell, S., & Weber, H. (2026). A' bhuinneach às dèidh trosgadh, breacan dubha anns an stòl & stiùireadh GI 2026. Rannsachadh Leigheis AI Kantesti.
📖 Iomraidhean Meidigeach Taobh a-muigh
📖 Lean ort a’ leughadh
Rannsaich barrachd stiùiridhean meidigeach air an ath-sgrùdadh le eòlaichean bhon Kantesti sgioba mheidigeach:

Anemia Ciall-corranach: Sgrìonadh, Comharran agus Comharran Èiginn
Mìneachadh Obair-lann Hematology 2026 Ùrachadh Chan e aon deuchainn, aon chomharra, no aon ìre a th’ ann an anemia ceallach corranach a tha càirdeil do dh’euslaintich...
Leugh an t-Artaigil →
Comharran Cirrhosis: Ciad Shoidhnichean agus Clàr-amhairc Deuchainn-fala
Slàinte an Grùthan Mìneachadh Leigheas 2026 Ùrachadh Duine-Càirdeil Bidh tràghad cirrhosis gu tric ag adhbhrachadh pian nach eil follaiseach: sgìths, atharrachaidhean cadail, lotan,...
Leugh an t-Artaigil →
Calproteactin an aghaidh Lactoferrin: A' Roghainn Deuchainn Stòil
Slàinte a' Ghiùrain Obrach-lann Eadar-mhìneachadh 2026 Ùrachadh Càirdeil do Dh'euslaintich Tha an dà dheuchainn a' lorg sè air an innidh a tha air a stiùireadh le neutrophil, ach mar as trice is e calprotectin an...
Leugh an t-Artaigil →
Deuchainn FIT Dheimhinich: Èiginn, Colonnoscopaidh agus na Ceumannan a Leanas
2026 Ath-ùrachadh air Eadar-mhìneachadh Lèigheil airson Sgrìonadh a' Ghalair: Cànan a tha furasta do dh'euslaintich Ma tha deuchainn FIT dearbhach a' ciallachadh gun deach haemaglòibin daonna a lorg anns na...
Leugh an t-Artaigil →
Adhbhan Fualach Maraichte: Nuair a dh’fheumas builgeanan leantainneach deuchainn
Mìneachadh Lab Slàinte Dubhaig Ùrachadh 2026 Càirdeil do Dh’euslaintich Cùpla builgeanan às deidh sruthadh fual luath mar as trice fiosaig....
Leugh an t-Artaigil →
Goir-fola san Fhual (an t-Ainm Laideann: Hematuria an Neach-ruithidh): Fual pinc às dèidh eacarsaich air a mhìneachadh
Leigheas Spòrs Searbhsacadh Fual 2026 Ùrachadh Aig an euslainteach: Is tric a bhios sampall fual pinc no dat-latha an dèidh ruith fhada...
Leugh an t-Artaigil →Faigh a-mach na h-uile stiùireadh slàinte againn agus innealan sgrùdaidh fala le cumhachd AI aig kantesti.net
⚕️ Àicheadh Meidigeach
Tha an artaigil seo dìreach airson adhbharan foghlaim agus chan eil e a’ dèanamh comhairle mheidigeach. Cuir fios an-còmhnaidh gu solaraiche cùram slàinte teisteanasach airson co-dhùnaidhean breithneachaidh is leigheis.
Comharran earbsa E-E-A-T
Eòlas
Lèirmheas clionaigeach air a stiùireadh le lighiche air sruthan-obrach mìneachaidh obair-lann.
Eòlas
Fòcas air leigheas obair-lann air mar a bhios bith-chomharraidhean (biomarkers) a’ giùlan ann an co-theacsa clionaigeach.
Ùghdarrasachd
Air a sgrìobhadh le Dr. Thomas Klein le ath-sgrùdadh le Dr. Sarah Mitchell agus Prof. Dr. Hans Weber.
Earbsachd
Mìneachadh stèidhichte air fianais le slighean leanmhainn soilleir gus dragh a lughdachadh.